What Are Letrozole Tablets USP 2.5 mg?
Letrozole Tablets USP 2.5 mg are prescription hormonal medicines containing letrozole, a potent nonsteroidal aromatase inhibitor.
Letrozole reduces estrogen production by blocking the aromatase enzyme.
Estrogen is a hormone involved in several normal physiological processes, including reproductive function and bone health.
Some breast cancers depend on estrogen signaling for growth.
These cancers are commonly described as hormone receptor-positive breast cancers.
In postmenopausal women, much of the body’s estrogen is produced through the conversion of androgen precursors into estrogens in peripheral tissues.
The aromatase enzyme plays a central role in this conversion.
Letrozole inhibits aromatase, significantly reducing circulating estrogen concentrations.
Lower estrogen availability can help slow or suppress the growth of estrogen-dependent breast cancer cells.
Letrozole is widely used as adjuvant endocrine therapy and in selected advanced or metastatic breast cancer treatment settings.
It may also be used after previous endocrine treatment, depending on the patient’s diagnosis and clinical circumstances.
Outside oncology, letrozole is used in fertility medicine to induce ovulation in selected patients, including some patients with polycystic ovary syndrome (PCOS).
This fertility use is off-label in many jurisdictions and follows a different dosing schedule from breast cancer treatment.
Important: Letrozole is not chemotherapy in the traditional cytotoxic sense. It is a hormonal anticancer medicine.
How Does Letrozole Work?
1. Inhibits the Aromatase Enzyme
Letrozole selectively inhibits aromatase, an enzyme responsible for estrogen synthesis.
2. Reduces Estrogen Production
Aromatase inhibition decreases the conversion of androgen precursors into estrogen.
3. Lowers Circulating Estrogen Levels
In postmenopausal women, letrozole can substantially reduce estrogen concentrations.
4. Reduces Estrogen-Dependent Tumor Stimulation
Certain breast cancer cells rely on estrogen receptor signaling for growth.
5. Helps Control Hormone Receptor-Positive Breast Cancer
By reducing estrogen availability, letrozole may slow the progression of estrogen-dependent tumors.
6. Supports Adjuvant Endocrine Therapy
After primary breast cancer treatment, letrozole may help reduce the risk of recurrence in appropriately selected patients.
7. Supports Advanced Breast Cancer Management
Letrozole may help control certain advanced or metastatic hormone receptor-positive breast cancers.
8. Influences Ovulation Through Hormonal Feedback
In fertility treatment, temporary estrogen suppression may increase follicle-stimulating hormone (FSH) activity, supporting follicular development and ovulation.
Important: Letrozole’s effects differ according to the treatment indication, hormonal status and prescribed regimen.
Uses of Letrozole Tablets USP 2.5 mg
1. Early Hormone Receptor-Positive Breast Cancer
Letrozole is used as adjuvant endocrine therapy in postmenopausal women with hormone receptor-positive early breast cancer.
2. Prevention of Breast Cancer Recurrence
Adjuvant letrozole may reduce the risk of recurrence after appropriate primary treatment.
3. Extended Adjuvant Endocrine Therapy
Letrozole may be prescribed after approximately five years of tamoxifen treatment in selected postmenopausal patients.
4. Advanced Breast Cancer
Letrozole may be used for selected advanced hormone receptor-positive breast cancers in postmenopausal women.
5. Metastatic Breast Cancer
It may be prescribed for certain metastatic breast cancers, sometimes in combination with other anticancer medicines.
6. Breast Cancer Following Previous Endocrine Therapy
Letrozole may be used after progression following certain previous hormonal treatments, depending on the clinical situation.
7. Hormonal Suppression in Estrogen-Dependent Breast Cancer
Letrozole reduces estrogen production, helping limit hormonal stimulation of susceptible tumor cells.
8. Ovulation Induction
Letrozole is used off-label in many countries to stimulate ovulation in selected patients with infertility.
9. Polycystic Ovary Syndrome (PCOS)
Letrozole is commonly recommended in fertility guidelines as a first-line pharmacological ovulation induction option for certain patients with PCOS-related anovulatory infertility.
10. Selected Fertility Treatment Protocols
Fertility specialists may prescribe letrozole as part of monitored ovulation induction or assisted reproduction protocols.
Important: Fertility treatment with letrozole must be supervised by a qualified healthcare professional. Existing pregnancy must be excluded before starting an ovulation induction cycle.
How to Take Letrozole Tablets USP 2.5 mg
Letrozole should be taken exactly as prescribed.
General Administration Instructions
- Confirm the prescribed strength and treatment indication.
- Swallow the tablet with water.
- Take it with or without food.
- Follow the prescribed schedule.
- For breast cancer treatment, take it at approximately the same time each day.
- Do not change the dose without medical advice.
- Do not discontinue long-term oncology treatment without consulting the treating specialist.
- Inform the healthcare professional about other medicines and supplements.
- Attend scheduled follow-up appointments.
- Report persistent or severe adverse effects.
Dosage Information
| Treatment Indication | General Dosage Guidance |
|---|---|
| Early Breast Cancer | Commonly 2.5 mg Once Daily |
| Advanced Breast Cancer | Commonly 2.5 mg Once Daily |
| Extended Adjuvant Therapy | Commonly 2.5 mg Once Daily |
| Ovulation Induction | Short-Course, Cycle-Specific Dosing Under Fertility Specialist Supervision |
| PCOS-Related Anovulation | Individualized Fertility Treatment Regimen |
| Treatment Duration for Breast Cancer | Often Several Years, Depending on the Treatment Plan |
| Fertility Treatment Duration | Usually Limited to Specific Days of the Menstrual Cycle |
| Severe Liver Impairment | Dose Adjustment May Be Required |
| Missed Dose | Follow Prescribing Instructions |
| Dose Adjustment | Only Under Medical Supervision |
Important: The standard breast cancer dose of letrozole is generally 2.5 mg once daily.
Fertility treatment uses a different, short-course dosing approach and should not be confused with continuous oncology dosing.
Can Letrozole Be Taken With Food?
Yes. Letrozole can generally be taken with or without food.
Can Letrozole Be Taken Every Day?
Yes. For breast cancer treatment, it is commonly prescribed once daily.
Can Letrozole Be Used for Fertility Treatment?
Yes. It may be prescribed off-label for ovulation induction in selected patients.
Can Letrozole Be Used During Pregnancy?
No. Letrozole can cause fetal harm and should not be taken during an established pregnancy.
What If a Dose Is Missed?
Take the missed dose when remembered unless it is nearly time for the next scheduled dose.
Do not double the dose.
For fertility treatment, contact the prescribing specialist because timing within the menstrual cycle is important.
What If Too Much Letrozole Is Taken?
Seek medical advice promptly.
Overdose management may require clinical observation and supportive treatment.
How Long Does Letrozole Take to Work?
The timing of response depends on the treatment indication.
During the First Several Days
Letrozole begins inhibiting aromatase and reducing estrogen production.
During Breast Cancer Treatment
Clinical and treatment-related benefits develop over time.
During Long-Term Adjuvant Therapy
The goal is to reduce the risk of breast cancer recurrence over an extended treatment period.
During Advanced Breast Cancer Treatment
Response is evaluated through symptoms, examinations and imaging studies.
During Fertility Treatment
Ovulation may occur after a prescribed short course, but timing varies between patients and cycles.
Important: Letrozole does not guarantee tumor response, pregnancy or successful ovulation.
Common Side Effects
Possible side effects include:
- Hot Flashes
- Joint Pain
- Muscle Pain
- Fatigue
- Headache
- Dizziness
- Nausea
- Increased Sweating
- Hair Thinning
- Weakness
- Bone Pain
- Sleep Disturbances
- Weight Changes
- Elevated Cholesterol
- Mild Swelling
Not every patient experiences these effects.
Serious Side Effects
Seek urgent medical attention if any of the following occur:
- Chest Pain
- Sudden Shortness of Breath
- Stroke-Like Symptoms
- Severe Allergic Reactions
- Significant Bone Pain or Suspected Fracture
- Severe Persistent Dizziness
- Significant Visual Disturbances
- Severe Weakness
- Yellowing of the Skin or Eyes
Important Serious Risks
1. Bone Mineral Density Reduction
Letrozole reduces estrogen levels and may accelerate bone loss.
2. Osteoporosis
Long-term treatment may increase the risk of osteoporosis.
3. Bone Fractures
Reduced bone mineral density can increase fracture risk.
4. Elevated Cholesterol
Letrozole may increase serum cholesterol concentrations.
5. Cardiovascular Events
Cardiovascular risks should be considered in patients receiving long-term endocrine therapy.
6. Liver Function Abnormalities
Liver enzyme elevations and rare clinically significant liver injury may occur.
7. Severe Hypersensitivity Reactions
Serious allergic reactions require urgent medical assessment.
8. Fetal Harm
Letrozole can cause fetal harm if administered during pregnancy.
Contraindications & Precautions
1. Pregnancy
Letrozole is contraindicated during pregnancy because of potential fetal harm.
2. Breastfeeding
Breastfeeding is not recommended during treatment and for the period specified in the product labeling after the final dose.
3. Hypersensitivity
Patients with known serious hypersensitivity to letrozole or formulation ingredients should avoid the medicine.
4. Premenopausal Status
Routine breast cancer treatment with letrozole is generally intended for postmenopausal patients.
Use in premenopausal breast cancer requires an appropriate specialist-directed treatment strategy, often involving ovarian function suppression.
5. Osteoporosis
Patients with osteoporosis require careful bone health assessment.
6. Bone Mineral Density Monitoring
Bone density testing may be recommended before and during long-term treatment.
7. High Cholesterol
Lipid monitoring may be appropriate during treatment.
8. Cardiovascular Disease
Patients with existing cardiovascular disease require individualized assessment.
9. Severe Liver Impairment
Dose adjustment and additional monitoring may be necessary.
10. Kidney Impairment
Renal function should be considered when selecting treatment.
11. Fertility Treatment
Pregnancy must be excluded before initiating letrozole for ovulation induction.
12. Menstrual Cycle Monitoring
Fertility specialists may monitor follicular development and ovulation response.
13. Driving and Machinery
Dizziness or fatigue may affect the ability to drive or operate machinery.
14. Hormonal Medicines
Estrogen-containing medicines may interfere with the intended estrogen-suppressing effects of letrozole.
15. Drug Interactions
Patients should disclose all prescription medicines, over-the-counter products and supplements.
16. Long-Term Therapy
Long-term treatment requires ongoing assessment of benefits and adverse effects.
17. Treatment Adherence
Consistent use is important for prescribed breast cancer endocrine therapy.
18. Medical Monitoring
Healthcare professionals may monitor:
- Breast Cancer Treatment Response
- Symptoms of Recurrence
- Bone Mineral Density
- Fracture Risk
- Serum Cholesterol
- Cardiovascular Risk
- Liver Function When Indicated
- Kidney Function When Indicated
- Joint and Muscle Symptoms
- Treatment Adherence
- Menopausal Status
- Pregnancy Status When Relevant
- Ovulation Response During Fertility Treatment
- Follicular Development When Indicated
- Medication Tolerability
- Overall Clinical Condition
Potential Therapeutic Advantages
- Aromatase Inhibition.
- Estrogen Production Suppression.
- Hormone Receptor-Positive Breast Cancer Treatment.
- Early Breast Cancer Adjuvant Therapy.
- Extended Adjuvant Endocrine Therapy.
- Advanced Breast Cancer Management.
- Metastatic Breast Cancer Treatment.
- Oral Once-Daily Administration.
- Established Endocrine Therapy.
- Selected Ovulation Induction Use.
- PCOS-Related Fertility Treatment.
- Prescription Hormonal Therapy.
- Specialist-Supervised Treatment.
Disadvantages / Limitations
- Hot Flashes.
- Joint Pain.
- Muscle Pain.
- Fatigue.
- Headache.
- Dizziness.
- Bone Mineral Density Reduction.
- Osteoporosis Risk.
- Fracture Risk.
- Elevated Cholesterol.
- Possible Cardiovascular Effects.
- Liver Function Abnormalities.
- Pregnancy Contraindication.
- Breastfeeding Restrictions.
- Requires Long-Term Monitoring.
- Requires Medical Supervision.
Important Notes
Generic Name: Letrozole.
Strength: 2.5 mg.
Pharmaceutical Standard: USP.
Drug Class: Nonsteroidal Aromatase Inhibitor.
Therapeutic Category: Anticancer Hormonal Therapy.
Primary Use: Hormone Receptor-Positive Breast Cancer.
Additional Use: Off-Label Ovulation Induction.
Mechanism of Action: Aromatase Inhibition.
Route: Oral.
Dosage Form: Tablet.
Standard Oncology Dose: 2.5 mg Once Daily.
Major Long-Term Risk: Bone Mineral Density Reduction.
Pregnancy: Contraindicated.
Medical Supervision: Required.
Frequently Asked Questions
1. What are Letrozole Tablets USP 2.5 mg used for?
Letrozole is primarily used to treat certain hormone receptor-positive breast cancers in postmenopausal women. It is also used off-label for ovulation induction in selected fertility patients.
2. What is the active ingredient in Letrozole Tablets?
The active ingredient is letrozole.
3. What does USP mean in Letrozole Tablets USP?
USP refers to the United States Pharmacopeia, which establishes pharmaceutical quality standards.
4. Is letrozole a chemotherapy medicine?
Letrozole is an endocrine anticancer medicine, not traditional cytotoxic chemotherapy.
5. How does letrozole work?
It inhibits aromatase, reducing estrogen production.
6. Is letrozole used for breast cancer?
Yes. It is widely used for certain hormone receptor-positive breast cancers.
7. Can letrozole reduce breast cancer recurrence?
Adjuvant letrozole may reduce recurrence risk in appropriately selected patients.





























































